Asm Iskander
Impact in
- Genetics top 5%
- Glioma Diagnosis and Treatment
- Mesenchymal stem cell research
-
- Circadian rhythm and melatonin
Papers in
-
- Angiogenesis and VEGF in Cancer 9
- RNA Interference and Gene Delivery 2
- Genetics 10
- Glioma Diagnosis and Treatment 9
- Co-authors
- Ali S. Arbab (35 shared papers)Adarsh Shankar (19 shared papers)Branislava Janic (15 shared papers)Thaiz F. Borin (15 shared papers)Meser M. Ali (11 shared papers)Nadimpalli R. S. Varma (10 shared papers)Ali M. Rad (6 shared papers)Hamid Soltanian‐Zadeh (7 shared papers)
- Journals
- PLoS ONE (11 papers)Cancer Research (4 papers)Journal of Magnetic Resonance Imaging (2 papers)Scientific Reports (2 papers)Anti-Cancer Agents in Medicinal Chemistry (1 paper)
- Partner nations
- United StatesBrazilIran
In The Last Decade
Asm Iskander
37 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 115
- Genetics 273
- Endocrine and Autonomic Systems 163
- Cancer Research 249
- Developmental Neuroscience 47
- Immunology 188
Countries citing papers authored by Asm Iskander
This map shows the geographic impact of Asm Iskander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asm Iskander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asm Iskander more than expected).
Fields of papers citing papers by Asm Iskander
This network shows the impact of papers produced by Asm Iskander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asm Iskander. The network helps show where Asm Iskander may publish in the future.
Co-authors
The 25 scholars most cited alongside Asm Iskander, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 172 | |
| 2 | 2015 | 113 | |
| 3 | 2007 | 87 | |
| 4 | 2010 | 68 | |
| 5 | 2018 | 59 | |
| 6 | 2007 | 57 | |
| 7 | 2010 | 51 | |
| 8 | 2009 | 49 | |
| 9 | 2013 | 48 | |
| 10 | 2015 | 46 | |
| 11 | 2017 | 46 | |
| 12 | 2013 | 39 | |
| 13 | 2017 | 38 | |
| 14 | 2015 | 37 | |
| 15 | 2014 | 36 | |
| 16 | 2013 | 33 | |
| 17 | 2012 | 28 | |
| 18 | 2009 | 27 | |
| 19 | 2012 | 24 | |
| 20 | 2017 | 24 |
About Asm Iskander
Asm Iskander is a scholar working on Molecular Biology, Genetics, Immunology, Cancer Research and Oncology, having authored 37 papers that have together received 1.3k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (9 papers), Glioma Diagnosis and Treatment (9 papers), Immune cells in cancer (8 papers), Cancer, Hypoxia, and Metabolism (7 papers), MRI in cancer diagnosis (3 papers), Nanoparticle-Based Drug Delivery (3 papers), Eicosanoids and Hypertension Pharmacology (3 papers) and RNA Interference and Gene Delivery (2 papers). The work is most often cited by research in Genetics (273 citations), Endocrine and Autonomic Systems (163 citations), Cancer Research (249 citations), Developmental Neuroscience (47 citations) and Immunology (188 citations). Asm Iskander has collaborated with scholars based in United States, Brazil and Iran. Frequent co-authors include Ali S. Arbab, Adarsh Shankar, Branislava Janic, Thaiz F. Borin, Meser M. Ali, Nadimpalli R. S. Varma, Ali M. Rad, Hamid Soltanian‐Zadeh, Nadimpalli Ravi S. Varma and Débora Aparecida Pires de Campos Zuccari. Their work appears in journals such as PLoS ONE, Cancer Research, Journal of Magnetic Resonance Imaging, Scientific Reports and Anti-Cancer Agents in Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.